Overview

3TC or No 3TC for HIV With 3TC Resistance

Status:
Suspended

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the effects of continuing or discontinuing 3TC treatment in the presence of HIV virus with 3TC resistance for persons who are on a regimen including least three other anti-HIV drugs. The overall aim is to determine whether continuing 3TC is of benefit in HIV-positive persons who have already shown resistance to this drug.

Phase:

Phase 4

Details

Lead Sponsor:

University of British Columbia

Collaborator:

CIHR Canadian HIV Trials Network

Treatments:

Lamivudine